Gilead Sciences’ already dominant position in HIV pre-exposure prophylaxis (PrEP) has been consolidated by a new study showing that its twice-yearly injectable drug was 100% effective in protecting ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Buying the wrong CIA ...

ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after three monthly doses.-    ASC30 SQ depo ...

LawCrossing has released its Law Firm Culture Index 2026, a comprehensive report examining workplace culture across major law firms. The annual index evaluates ...

EurekAlert! is an online science news service featuring health, medicine, science and technology news from leading research institutions and universities. Sponsored by AAAS, the science society.